|Day Low/High||41.60 / 42.25|
|52 Wk Low/High||26.90 / 44.09|
Cabela's also restructured a deal to eventually sell its credit card unit to Capital One.
We are selling our holdings in Synovus Financial on today's strength. Plus, an update on TherapeuticsMD.
And, remember that today is tax day. It is also the first heavy day for this earnings seasons.
Cabela's stock was on the move in Monday's after-hours session.
We added a new name to the portfolio as the market took a breather in a shortened trading week.
Synovus Financial Corp. (NYSE: SNV) today reported financial results for the quarter ended March 31, 2017.
Our concern about slowing loan growth in the banking sector has led us to reduce our rating on Synovus Financial to a Three from a Two.
The Board of Directors of Synovus Financial Corp. (NYSE: SNV) has declared a dividend of $0.
Synovus Financial Corp. (NYSE: SNV) will announce first quarter 2017 results on Tuesday, April 18, 2017.
We beat the benchmark Russell 2000 for the quarter, and we await a busy week on the economic front.
Synovus and Huntington Bancshares are both trading up today, tracking the rise of 10-Year Treasury yields.
We are keeping an eye on rate-sensitive names for possible buying opportunities, as stocks fell around 1.5% this week.
We picked up more Abraxas Petroleum on weakness, while the market rebounded slightly after the FOMC announced the anticipated quarter-point rate hike.
Shareholders of Synovus Financial and Huntington Bancshares will qualify for payouts this week.
We bulked up on Abraxas Petroleum and Yamana Gold on weakness, as the markets pulled back and investors positioned for next week’s FOMC meeting.
We booked some profits in Huntington Bancshares and Builders FirstSource, while markets digested the likelihood of a March rate hike.
We believe the company can continue to post above-average growth in the coming quarters.
The Board of Directors of Synovus Financial Corp. (NYSE: SNV) has declared a quarterly dividend of $0.
We opened a new position in Abraxas Petroleum on its above-average growth potential, as stocks faced selling pressure this week.
Synovus (NYSE: SNV) has won 28 awards in the 2016 Greenwich Excellence Awards for Small Business Banking and Middle Market Banking.
We closed out our position in OraSure Technologies for an average gain of 105% gain.
Small cap investors banking the big Trump rally gains should prepare to switch investing strategies to pursue active investment philosophies.
We used some of the proceeds to boost our stake in Jive Software this week. In addition, we initiated a position in drug-delivery system developer, Antares Pharma.
We used a price decline to add to our position in TherapeuticsMD this week.
We’d look to purchase Builders FirstSource, Jive Software and TherapeuticsMD on near-term declines.
Synovus Financial Corp. (NYSE: SNV) announced the appointment of F.
We would consider adding to our position at around $38.